Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bahattin Özkul, Furkan Ertürk Urfalı, İbrahim Halil Sever, Mehmet Fatih Bozkurt, İbrahim Söğüt, Çağrı Serdar Elgörmüş, Mumin Alper Erdogan & Oytun Erbaş. (2022) Demonstration of ameliorating effect of vardenafil through its anti-inflammatory and neuroprotective properties in autism spectrum disorder induced by propionic acid on rat model. International Journal of Neuroscience 132:11, pages 1150-1164.
Read now
Read now
Articles from other publishers (24)
Ahmed K. ElHady, Dalia S. El-Gamil, Mohammad Abdel-Halim & Ashraf H. Abadi. (2023) Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives. Pharmaceuticals 16:9, pages 1266.
Crossref
Crossref
Raed AlRuwaili, Hayder M. Al-kuraishy, Mubarak Alruwaili, Amira Karam Khalifa, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad & Gaber El-Saber Batiha. (2023) The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS). Molecular and Cellular Biochemistry.
Crossref
Crossref
Tugba ERTAN-BOLELLİ, Kayhan BOLELLİ, Cisem ALTUNAYAR-UNSALAN, Ozan ÜNSALAN & Bergüzar YILMAZ. (2023) Effects of flavonoids on SARS–CoV–2 main protease (6W63): A molecular docking study. Turkish Computational and Theoretical Chemistry 7:2, pages 34-57.
Crossref
Crossref
Shristi Modanwal, Viswajit Mulpuru & Nidhi Mishra. 2023. COVID-19: Origin, Impact and Management (Part 2). COVID-19: Origin, Impact and Management (Part 2)
96
110
.
Ayame Kobayashi, Motokuni Nakajima, Yoh Noguchi, Ryota Morikawa, Yukiko Matsuo & Masako Takasu. (2023) Molecular Dynamics Simulation of the Complex of PDE5 and Evodiamine. Life 13:2, pages 578.
Crossref
Crossref
Silvia Limoncella, Clara Lazzaretti, Elia Paradiso, Sara D'Alessandro, Federica Barbagallo, Salvatore Pacifico, Remo Guerrini, Simonetta Tagliavini, Tommaso Trenti, Daniele Santi, Manuela Simoni, Marco Sola, Giulia Di Rocco & Livio Casarini. (2022) Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line. Molecular and Cellular Endocrinology 542, pages 111527.
Crossref
Crossref
Giuseppe Defeudis, Rossella Mazzilli, Marta Tenuta, Giovanni Rossini, Virginia Zamponi, Soraya Olana, Antongiulio Faggiano, Paolo Pozzilli, Andrea M. Isidori & Daniele Gianfrilli. (2021) Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes/Metabolism Research and Reviews 38:2.
Crossref
Crossref
Mehmet Cem Sabaner, Mustafa Dogan, Muberra Akdogan, Serdar Karadag, Ismail Umut Onur, Ali İhsan Tasci & Fadime Ulviye Yigit. (2021) Evaluation of Retinal and Choroidal Microcirculation Alterations After a Single Dose of Oral 5-mg Tadalafil: A Prospective Pilot Optical Coherence Tomography Angiography Study. Journal of Ocular Pharmacology and Therapeutics 37:7, pages 421-429.
Crossref
Crossref
Rick H. Cote. (2021) Photoreceptor phosphodiesterase (PDE6): activation and inactivation mechanisms during visual transduction in rods and cones. Pflügers Archiv - European Journal of Physiology 473:9, pages 1377-1391.
Crossref
Crossref
Erika L. Poitras, Stephen L. Gust, Paul M. Kerr & Frances Plane. (2021) Repurposing of the PDE5 Inhibitor Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Neonates. Current Medicinal Chemistry 28:12, pages 2418-2437.
Crossref
Crossref
Moein Ala, Razieh Mohammad Jafari & Ahmad Reza Dehpour. (2020) Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications. Fundamental & Clinical Pharmacology 35:2, pages 235-259.
Crossref
Crossref
Eva Ausó, Violeta Gómez-Vicente & Gema Esquiva. (2021) Visual Side Effects Linked to Sildenafil Consumption: An Update. Biomedicines 9:3, pages 291.
Crossref
Crossref
Ahmed K. ElHady, Shou-Ping Shih, Yu-Cheng Chen, Yi-Chang Liu, Nermin S. Ahmed, Adam B. Keeton, Gary A. Piazza, Matthias Engel, Ashraf H. Abadi & Mohammad Abdel-Halim. (2020) Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors. Bioorganic Chemistry 98, pages 103742.
Crossref
Crossref
Claire Lugnier, Alain Meyer, Samy Talha & Bernard Geny. (2020) Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?. Pharmacology & Therapeutics 208, pages 107475.
Crossref
Crossref
Ivan Pires de Oliveira, Caroline Honaiser Lescano & Gilberto De Nucci. (2019) In Silico Mapping of Essential Residues in the Catalytic Domain of PDE5 Responsible for Stabilization of Its Commercial Inhibitors. Scientia Pharmaceutica 87:4, pages 29.
Crossref
Crossref
A. Zucchi, E. Costantini, F. I. Scroppo, M. Silvani, Z. Kopa, E. Illiano, M. G. Petrillo, L. Cari & G. Nocentini. (2019) The first‐generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue. Andrology 7:6, pages 804-817.
Crossref
Crossref
Nermin S. Ahmed. (2018) Tadalafil: 15 years' journey in male erectile dysfunction and beyond. Drug Development Research 80:6, pages 683-701.
Crossref
Crossref
Jason G. Pattis, Shaan Kamal, Boyang Li & Eric R. May. (2019) Catalytic Domains of Phosphodiesterase 5, 6, and 5/6 Chimera Display Differential Dynamics and Ligand Dissociation Energy Barriers. The Journal of Physical Chemistry B 123:4, pages 825-835.
Crossref
Crossref
Antonio-Jesús Banegas-Luna, José P Cerón-Carrasco & Horacio Pérez-Sánchez. (2018) A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data. Future Medicinal Chemistry 10:22, pages 2641-2658.
Crossref
Crossref
Hongbo Zheng, Yifeng Wu, Bin Sun, Chuanle Cheng, Yanan Qiao, Yuehua Jiang, Shengtian Zhao, Zhiyu Xie, Jing Tan & Hongxiang Lou. (2018) Discovery of furyl/thienyl β-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect. European Journal of Medicinal Chemistry 158, pages 767-780.
Crossref
Crossref
F. Marampon, C. Antinozzi, C. Corinaldesi, G. B. Vannelli, E. Sarchielli, S. Migliaccio, L. Di Luigi, A. Lenzi & C. Crescioli. (2017) The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism. Endocrine 59:3, pages 602-613.
Crossref
Crossref
Gülru Kayık, Nurcan Ş. Tüzün & Serdar Durdagi. (2017) Structural investigation of vesnarinone at the pore domains of open and open-inactivated states of hERG1 K + channel. Journal of Molecular Graphics and Modelling 77, pages 399-412.
Crossref
Crossref
Anand Gaurav, Ming Xing & Mayasah Al‐Nema. 2017. Quantitative Structure-activity Relationship. Quantitative Structure-activity Relationship.
Luigi Di Luigi, Massimiliano Sansone, Andrea Sansone, Roberta Ceci, Guglielmo Duranti, Paolo Borrione, Clara Crescioli, Paolo Sgrò & Stefania Sabatini. (2017) Phosphodiesterase Type 5 Inhibitors, Sport and Doping. Current Sports Medicine Reports 16:6, pages 443-447.
Crossref
Crossref